Navigation Links
Genetics Influence Blood Pressure Medications

A person's gene profile seems to dictate reponse, study finds

TUESDAY, Jan. 22 (HealthDay News) -- A person's genetic make-up seems to influence how he or she reacts to certain hypertension medications.

In the future, being able to match genes with medications may help save a patient's life, experts predict.

"This is potentially a very, very important observation. It's a large study with hard clinical endpoints," said Dr. Joshua M. Hare, chief of cardiology at the University of Miami Miller School of Medicine. "This is a beautiful example of what we anticipate personalized medicine to be," said Hare, who was not involved in the research.

Another expert agreed. Dr. Jeffery Vance, professor at the Miami Institute for Human Genomics, said that "This is where medicine is going. It's important that we've got big clinical trials [showing this]. They cost a lot of money but this shows that it's clearly worth it."

The gene variant identified in the new study is likely to be just one of several that play a role in hypertension, also known as high blood pressure.

"Hypertension is such a complex disease. There are many different mechanisms that help us regulate our blood pressure so we would not expect any one gene to have a really large effect for [such] a common condition like hypertension," noted study senior author Donna K. Arnett, professor and chair of the University of Alabama at Birmingham's department of epidemiology. "That we found this effect is important because we didn't think we would ever be able to do pharmacogenetics, given the complexity of hypertension."

According to background information with the study, published in the Jan. 23 issue of the Journal of the American Medical Association, some 65 million people in the United States have hypertension. But only about two-thirds have their condition under control. Uncontrolled hypertension can lead to such problems as heart attack and stroke.

Previous studies have shown that the presence of certain gene characteristics can predict response to treatments such as ACE inhibitors, which are drugs used to control hypertension. But this information hasn't been adopted widely by doctors.

The new study focused on the NPPA (atrial natriuretic precursor A) gene, which is involved in forming atrial natriuretic polypeptide, which acts as a diuretic.

Specifically, the study authors wanted to see if people with hypertension and two different NPPA genotypes (known as NPPA G664A and NPPA T2238C) responded differently to different medications.

In all, 38,462 people with hypertension underwent genotyping [genetic testing] and were randomly assigned to receive a diuretic (chlorthalidone) or one of the following three drugs: a calcium channel blocker (amlodipine); an angiotensin converting enzyme inhibitor (lisinopril); or an alpha-blocker (doxazosin).

People with the more common subtype of the NPPA gene responded better to the calcium channel blocker than the diuretic. There were no differences in response between the diuretic and the other two drugs studied, the researchers said.

People with the other genotype fared better on the diuretic.

"Eventually we should be able to utilize prescreening for treatment to determine which drug you may respond best to," Arnett said. "This is a small but important step towards personalized medicine."

More information

The American Heart Association has more on high blood pressure.

SOURCES: Joshua M. Hare, M.D., chief of cardiology, University of Miami Miller School of Medicine; Jeffery Vance, M.D., Ph.D., professor, Miami Institute for Human Genomics; Donna K. Arnett, Ph.D., chair and professor, department of epidemiology, University of Alabama at Birmingham; Jan. 23, 2008, Journal of the American Medical Association

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. People with anorexia less likely to be blamed when biology, genetics explained
2. Top10 research advances include studies on genetics and stem cell research, stents
3. Heart attack risk from smoking due to genetics
4. Genetics May Boost Mexican-Americans Risk for Alcoholism
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
6. Researchers develop powerful tool to study the genetics of inflammation
7. deCODE genetics to Webcast Presentation at Piper Jaffray Annual Healthcare Conference
8. deCODE genetics to Webcast Presentation at Lazard Capital Markets Annual Healthcare Conference
9. Genetics and Risk, This Week on Your Cancer Today(TM)
10. CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development
11. Response Genetics Reports Third Quarter 2007 Financial Results
Post Your Comments:
Related Image:
Genetics Influence Blood Pressure Medications
(Date:11/27/2015)... ... 2015 , ... An inventor, from Hopkinsville, Ky., thought there ... home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. provides ... so, it could help to prevent potential overdose situations. As a result, it ...
(Date:11/27/2015)... Aliso Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... exclusively for use in Final Cut Pro X. With ProSidebar: Fasion, video editors ... banners, or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television ... an interesting show that delves into an array of issues that are presently affecting ... benefit from open dialogue, this show is changing the subjects consumers focus on, one ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and ... nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown commitment ... advance the healthcare industry as a whole through their advocacy and professional efforts. ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ... acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the ... company UCB S.A. (Euronext: UCB). ... KU from UCB for total consideration of approximately ... customary working capital adjustment, a deduction of certain ...
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
Breaking Medicine Technology: